| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 263 | 202 | 276 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 263 | 202 | 276 | | | Operating Expenses | | Research Development | 10,924 | 14,327 | 10,015 | | Selling General and Administrative | 7,304 | 7,535 | 5,072 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (17,964) | (21,660) | (14,812) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,193 | (1,288) | (5,635) | | Earnings Before Interest And Taxes | (16,771) | (22,948) | (20,447) | | Interest Expense | 462 | 2,239 | 1,948 | | Income Before Tax | (17,233) | (25,187) | (22,395) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,233) | (25,187) | (22,395) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (17,233) | (25,187) | (22,395) | | Preferred Stock And Other Adjustments |
-
| (3,871) | (65) | | | Net Income Applicable To Common Shares | ($17,233) | ($29,058) | ($22,460) |
|
0.34% Nasdaq 
0.15 (3.75%) 
Income Statement
